Research Research Research InterestDepartment Equipment & Facilities​Selected Publications Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial Read more Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohortwith high prevalence of concomitant cerebrovascular disease Read more Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition Read more Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy Read more Collagen deposition in lung parenchyma driven by depletion of interstitial Lyve-1+ macrophages prevents cigarette smoke-induced emphysema and loss of airway function Read more Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management Read more Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials Read more Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation Read more Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases Read more ARID1A is a coactivator of STAT5 that contributes to CD8+ T cell dysfunction and anti-PD-1 resistance in gastric cancer Read more Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma Read more Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer Read more « Previous 1 … 3 4 5 6 7 8 Next »
